Read + Share
Amedeo Smart
Independent Medical Education
Hariyanto TI, Kurniawan A. Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection. J Med Virol 2020 Nov 26. doi: 10.1002/jmv.26698.PMID: 33241872
Email
LinkedIn
Facebook
Twitter
Privacy Policy